Cargando…
Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection
Patients infected with SARS‐CoV‐2 have varying manifestations of cardiac involvement. We report four patients presenting with symptomatic cardiac sarcoidosis (CS) or giant cell myocarditis (GCM) 1–8 months after mild COVID‐19. All patients received immunosuppressive therapy and improved gradually wi...
Autores principales: | Bollano, Entela, Polte, Christian Lars, Mäyränpää, Mikko I., Oldfors, Anders, Bergh, Niklas, Lehtonen, Jukka, Kandolin, Riina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539072/ https://www.ncbi.nlm.nih.gov/pubmed/35996829 http://dx.doi.org/10.1002/ehf2.14088 |
Ejemplares similares
-
Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis
por: Bobbio, Emanuele, et al.
Publicado: (2021) -
Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experience
por: Bobbio, Emanuele, et al.
Publicado: (2022) -
Somatostatin receptor positron emission tomography/computed tomography in myocarditis following mRNA COVID-19 vaccination
por: Bollano, Entela, et al.
Publicado: (2022) -
Idiopathic giant cell myocarditis or cardiac sarcoidosis? A retrospective audit of a nationwide case series
por: Ekström, Kaj, et al.
Publicado: (2020) -
Cardiovascular Magnetic Resonance in Myocarditis
por: Polte, Christian L., et al.
Publicado: (2022)